TGA issued version 1.5 of its Australian Public Assessment Report (AusPAR) Guidance in mid-March. The AusPAR, published on the TGA website, includes information on the outcome of the evaluation process and the rationale for the decision to accept or to reject drug registrations.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]